RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Levodopa-Carbidopa Intestinal Gel Shows Promise in Advanced Parkinson Disease
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 9
SP 11
OP 11
DO 10.1177/1559897715588296
UL http://mdc.sagepub.com/content/15/9/11.2.abstract
AB Treatment with levodopa-carbidopa intestinal gel leads to reduction in nonmotor symptoms in patients with advanced Parkinson’s disease, with significantly lower Non-Motor Symptoms Scale total scores and scores for the individual domains of sleep/fatigue, sexual function, and miscellaneous. Safety results are similar to those seen in prior studies with levodopa-carbidopa intestinal gel.